Skip to main content
Equibles

Scott Koenig

CEO

Macrogenics Inc (MGNX)

Board Member

Macrogenics Inc (MGNX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Macrogenics Inc publishes a filing, an earnings call transcript or a press release.

Get MGNX alerts

About Scott Koenig

Scott Koenig is recorded as CEO and Board Member at Macrogenics Inc (MGNX). The newest filing on record that lists Scott Koenig as CEO and Board Member at Macrogenics Inc (MGNX) is dated April 8, 2026. The proxy statement of Macrogenics Inc reports total compensation of $952,961 for Scott Koenig in fiscal 2025, including a base salary of $477,120. Disclosed compensation is on record for 9 fiscal years. Scott Koenig has spoken on 17 earnings calls across 1 company, most recently for Macrogenics Inc on August 6, 2024. Macrogenics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Macrogenics Inc includes Eric Risser (CEO, COO and Board Member), William K. Heiden (Chairman and Board Member), James Karrels (CFO) and 7 others.

Scott Koenig on recent calls

“I'd like to welcome everyone participating via conference call and webcast today. I will provide key updates on our clinical programs this afternoon. But before I do so, let me first turn the call back to Jim, who will review our financial results.”
CEO, Macrogenics Inc Q2 FY2024 Earnings Call ·
“I'd like to welcome everyone participating via conference call and webcast today. I will provide key updates on our clinical programs, including an important interim data update on our TAMARACK Phase II study this afternoon.”
CEO, Macrogenics Inc Q1 FY2024 Earnings Call ·
“I'd like to welcome everyone participating via conference call and webcast today. I will provide key updates on our clinical programs this afternoon. But before I do so, let me first turn the call back to Jim, who will review our financial results.”
CEO, Macrogenics Inc Q4 FY2023 Earnings Call ·
“I’d like to welcome everyone participating via conference call and webcast today. This afternoon, I will provide key updates on our clinical programs. But before I do so, let me first turn the call back to Jim, who will review our financial results.”
CEO, Macrogenics Inc Q3 FY2023 Earnings Call ·
“I'd like to welcome everyone participating via conference call and webcast today. This afternoon, I will provide key updates on our clinical programs. But before I do so, let me first turn the call back to Jim, who will review our financial results.”
CEO, Macrogenics Inc Q2 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Macrogenics Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Macrogenics Inc (MGNX) $477,120 $952,961
2024 Macrogenics Inc (MGNX) $734,031 $6,403,448
2023 Macrogenics Inc (MGNX) $704,914 $3,705,825
2022 Macrogenics Inc (MGNX) $673,420 $4,627,948
2021 Macrogenics Inc (MGNX) $651,119 $4,868,514
2020 Macrogenics Inc (MGNX) $655,865 $3,111,288
2019 Macrogenics Inc (MGNX) $590,019 $4,723,588
2018 Macrogenics Inc (MGNX) $598,500 $5,205,733
2017 Macrogenics Inc (MGNX) $554,346 $3,478,130

Recent activity

Show 5 earlier activities